Halozyme Therapeutics
Price & Volume
Stats
See moreOpen | $62.25 |
Previous Close | $61.39 |
Day Range | $60.82-$62.25 |
52W Range | $37.73-$66 |
Market Cap | $7.5B |
Shares Short | 9M |
Financials
See moreRevenue (12 Mos) | $1B |
Revenue Growth (YoY) | 29.5% |
Gross Profit (12 Mos) | $776.8M |
Diluted EPS | $3.43 |
News
See moreYahoo Finance • last month
Update: Market Chatter: Merck Faces Patent Dispute Over New Keytruda Version
Yahoo Finance • 2 months ago
Halozyme Therapeutics, Inc. (HALO): A Cheap Biotech Stock to Invest In Now
Yahoo Finance • 12 months ago
Halozyme to Report First Quarter 2024 Financial and Operating Results
About
CEO | Dr. Helen I. Torley M.B. Ch. B., M.R.C.P. |
CFO | Ms. Nicole LaBrosse CPA |
Address | 12390 El Camino Real, San Diego, CA, United States, 92130 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 350 |
